Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 01, 2024

SELL
$2.06 - $2.99 $57,801 - $83,896
-28,059 Reduced 89.8%
3,186 $8,000
Q1 2024

May 09, 2024

BUY
$2.04 - $2.38 $2,127 - $2,482
1,043 Added 3.45%
31,245 $73,000
Q3 2023

Nov 09, 2023

BUY
$2.37 - $3.52 $4,552 - $6,761
1,921 Added 6.79%
30,202 $81,000
Q2 2023

Aug 08, 2023

BUY
$3.45 - $4.47 $97,569 - $126,416
28,281 New
28,281 $97,000
Q2 2021

Aug 05, 2021

SELL
$2.85 - $4.79 $65,595 - $110,246
-23,016 Closed
0 $0
Q1 2021

May 06, 2021

BUY
$3.28 - $5.82 $328 - $582
100 Added 0.44%
23,016 $81,000
Q4 2020

Feb 10, 2021

BUY
$3.78 - $7.36 $7,484 - $14,572
1,980 Added 9.46%
22,916 $138,000
Q3 2020

Nov 12, 2020

SELL
$6.69 - $10.94 $10,289 - $16,825
-1,538 Reduced 6.84%
20,936 $151,000
Q2 2020

Aug 13, 2020

BUY
$6.84 - $12.42 $153,722 - $279,127
22,474 New
22,474 $202,000

Others Institutions Holding KRMD

About KORU Medical Systems, Inc.


  • Ticker KRMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 45,033,100
  • Market Cap $159M
  • Description
  • KORU Medical Systems, Inc. designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. It offers mechanical infusion product comprising the FREEDOM infusion systems that include the FREEDOM60 syringe driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneou...
More about KRMD
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.